Inhibition of Experimental Bladder Tumor Induction by Systemic BCG Treatment
- 1 January 1981
- journal article
- research article
- Published by Elsevier in European Urology
- Vol. 7 (1), 35-38
- https://doi.org/10.1159/000473169
Abstract
Transitional cell carcinoma of the urinary bladder was induced in rats by ingestion of 0.188% N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide. During the induction period of 8 mo., 1 animal group received systemic BCG treatment. After 12 mo., the BCG-treated rats showed a significantly lower bladder tumor weight and stage than the corresponding controls. The results are discussed with regard to the possibility of BCG prophylaxis of human bladder tumors.This publication has 9 references indexed in Scilit:
- Bacillus Calmette-guerin Immunotherapy of Superficial Bladder CancerJournal of Urology, 1980
- Inhibition and promotion of tumor growth by BCG: Evidence for stimulation of humoral enhancing factors by BCGInternational Journal of Cancer, 1978
- Biological behavior of N-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide induced carcinoma of the transitional epithe-lium in the ratZeitschrift für Krebsforschung und Klinische Onkologie, 1978
- Inhibition or Enhancement of Rat Mammary Tumors Dependent on Dose of BCG2JNCI Journal of the National Cancer Institute, 1977
- Effect of Different Doses of BCG on an Allogeneic Cell-Mediated Antitumor Response in Mice: Brief Communication2JNCI Journal of the National Cancer Institute, 1977
- Intracavitary Bacillus Calmette-guerin in the Treatment of Superficial Bladder TumorsJournal of Urology, 1976
- Active Immunoprophylaxis and Immunotherapy in Two Mouse Lymphoma Models2JNCI Journal of the National Cancer Institute, 1976
- Suppression of Strontium-90-Induced Development of Bone Tumors by Infection with Bacillus Calmette-Guérin (BCG)Radiation Research, 1965
- Effect of BCG Infection on Leukemia and Polyoma in Mice and Hamsters.Experimental Biology and Medicine, 1962